MC
AMPH icon

Menta Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Menta Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,156
Closed -$224K – 797
2016
Q4 		$224K Sell
12,156
-81,736
-87% -$1.59M 0.02% 802
2016
Q3 		$1.78M Buy
93,892
+2,707
+3% +$49.1K 0.17% 201
2016
Q2 		$1.47M Buy
91,185
+46,805
+105% +$660K 0.2% 125
2016
Q1 		$533K Buy
+44,380
New +$523K 0.07% 464

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Menta Capital's AMPH Position: Q1 2017 in Review

Menta Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 12,156 shares — an estimated $224K sold.

Menta Capital first reported a position in AMPH in Q1 2016 and held it in 4 quarters. The position peaked at $1.78M in Q3 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Menta Capital reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Menta Capital sold 12,156 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $224K.
  • Menta Capital first reported a position in Amphastar Pharmaceuticals in Q1 2016 and held it in 4 quarters.
  • Menta Capital's Amphastar Pharmaceuticals position peaked at $1.78M in Q3 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.